HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Clinical trial NCT05902494 · COMPLETED

Trial details

NCT number: NCT05902494
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma

Start date: 2023-06-29
Primary completion: 2025-06-18
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.